About

Carole Delauney is Director Business Development at Swissfillon. She has 18 years’ expertise as a highly technically skilled commercial professional working at CMOs and CDMOs where it has been her responsibility to seek specific solutions adapted to the outsourcing needs of pharmaceutical and biotechnology companies. For the past 14 years her focus has been on sterile drug product manufacturing. Ms Delauney holds a five-year degree in Biochemistry.

Contributions

OCULAR

OPHTHALMIC DRUGS: PATHWAY TO OVERCOME PRIMARY PACKAGING AND DRUG PRODUCT MANUFACTURING CHALLENGES

Rainer Glöckler, Carole Delauney, Dr Nicolas Eon and Katsuyuki Takeuchi discuss the myriad complexities of developing drug products for intravitreal injection, and how the partnership between swissfillon and Terumo can ease and accelerate these products to market. The first article, published in April, covered how swissfillon’s state-of-the-art filling line meets the complex requirements of ophthalmic drug products.

More contributions

OCULAR

STATE-OF-THE-ART SOLUTIONS FOR OPHTHALMIC STERILE DRUG PRODUCT MANUFACTURING

In the first in a series of two articles, Rainer Glöckler and Carole Delauney discuss how the company’s state-of-the-art filling line meets the requirements and complexities that are particular to ophthalmic drug product manufacturing. The second article, to be published in May, will explore partnerships between pharma, CDMOs and syringe manufacturers in more detail.